SIRT1, a Calorie Restriction Mimetic, in a New Therapeutic Approach for Type 2 Diabetes Mellitus and Diabetic Vascular Complications

Publisher： Bentham Science Publishers

E-ISSN： 2212-3873|10|1|16-24

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.10, Iss.1, 2010-03, pp. : 16-24

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

SIRT1 as a Therapeutic Target in Diabetic Complications

By  

Current Medicinal Chemistry, Vol. 25, Iss. 9, 2018-03 ,pp. : 1002-1035

Bentham Science Publishers

Access to resources Recommend Favorite

Serum antibodies to collagen type IV and development of diabetic vascular complications in children with type 1 (insulin-dependent) diabetes mellitus - A longitudinal study

By Nicoloff G.   Baydanoff S.   Petrova C.   Christova P.  

General Pharmacology, Vol. 38, Iss. 3, 2002-03 ,pp. : 143-147

Elsevier

Access to resources Recommend Favorite

Relationship between Fasting and 2-hour Postprandial Plasma Glucose Levels and Vascular Complications in Patients with Type 2 Diabetes Mellitus

By Tanaka M  

The Journal of International Medical Research, Vol. 40, Iss. 4, 2012-07 ,pp. : 1295-1303

Field House Publishing

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor (VEGF) in the Pathogenesis of Diabetic Nephropathy of Type 1 Diabetes Mellitus

By  

Current Drug Targets, Vol. 12, Iss. 1, 2011-01 ,pp. : 107-114

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Targets for the Prevention of Type 1 Diabetes Mellitus

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 5, Iss. 2, 2005-06 ,pp. : 227-236

Bentham Science Publishers

Access to resources Recommend Favorite